B
B1 Neuro provides neurotargeting services that map functional brain networks using resting‑state fMRI to identify dysregulated circuits. The company integrates these network maps with transcranial magnetic stimulation (TMS) protocols to deliver precise, non‑invasive brain stimulation. This approach aims to improve outcomes for mental health disorders such as depression, anxiety, and ADHD.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- This startup provides brain analysis software that uses MRI data and machine learning to personalize brain stimulation treatments for psychiatric conditions. The software identifies optimal target locations for treatments like transcranial magnetic stimulation (TMS), aiming to improve patient outcomes, particularly for depression.